739 related articles for article (PubMed ID: 28384202)
1. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis.
Charkiewicz K; Goscik J; Blachnio-Zabielska A; Raba G; Sakowicz A; Kalinka J; Chabowski A; Laudanski P
PLoS One; 2017; 12(5):e0177601. PubMed ID: 28542236
[TBL] [Abstract][Full Text] [Related]
3. Blood sphingolipidomics in healthy humans: impact of sample collection methodology.
Hammad SM; Pierce JS; Soodavar F; Smith KJ; Al Gadban MM; Rembiesa B; Klein RL; Hannun YA; Bielawski J; Bielawska A
J Lipid Res; 2010 Oct; 51(10):3074-87. PubMed ID: 20660127
[TBL] [Abstract][Full Text] [Related]
4. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid Signature of Human Feto-Placental Vasculature in Preeclampsia.
Del Gaudio I; Sasset L; Lorenzo AD; Wadsack C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033121
[TBL] [Abstract][Full Text] [Related]
6. Bioactive lipid mediators in plasma are predictors of preeclampsia irrespective of aspirin therapy.
Stephenson DJ; MacKnight HP; Hoeferlin LA; Washington SL; Sawyers C; Archer KJ; Strauss JF; Walsh SW; Chalfant CE
J Lipid Res; 2023 Jun; 64(6):100377. PubMed ID: 37119922
[TBL] [Abstract][Full Text] [Related]
7. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
9. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
[TBL] [Abstract][Full Text] [Related]
10. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
[TBL] [Abstract][Full Text] [Related]
12. First and second trimester immune biomarkers in preeclamptic and normotensive women.
Taylor BD; Ness RB; Klebanoff MA; Zoh R; Bass D; Hougaard DM; Skogstrand K; Haggerty CL
Pregnancy Hypertens; 2016 Oct; 6(4):388-393. PubMed ID: 27939488
[TBL] [Abstract][Full Text] [Related]
13. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
[TBL] [Abstract][Full Text] [Related]
14. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
[TBL] [Abstract][Full Text] [Related]
15. Early-pregnancy prediction of risk for pre-eclampsia using maternal blood leptin/ceramide ratio: discovery and confirmation.
Huang Q; Hao S; You J; Yao X; Li Z; Schilling J; Thyparambil S; Liao WL; Zhou X; Mo L; Ladella S; Davies-Balch SR; Zhao H; Fan D; Whitin JC; Cohen HJ; McElhinney DB; Wong RJ; Shaw GM; Stevenson DK; Sylvester KG; Ling XB
BMJ Open; 2021 Nov; 11(11):e050963. PubMed ID: 34824115
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic collagen fragment arresten is increased from 16 weeks' gestation in pre-eclamptic plasma.
Yong HE; Murthi P; Wong MH; Kalionis B; Brennecke SP; Keogh RJ
Placenta; 2015 Nov; 36(11):1300-9. PubMed ID: 26343951
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
[TBL] [Abstract][Full Text] [Related]
18. Plasma Level of Placenta-Derived Macrophage-Stimulating Protein -Chain in Preeclampsia before 20 Weeks of Pregnancy.
Zhang Y; Yang H; Long Y; Ma Q; Chen R
PLoS One; 2016; 11(8):e0161626. PubMed ID: 27559727
[TBL] [Abstract][Full Text] [Related]
19. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
[TBL] [Abstract][Full Text] [Related]
20. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
